At the time of the investment in Charles River in 1999, the company was a worldwide leader in commercial production and supply of live research models for scientific and pharmaceutical research and development and a leading supplier of related biomedical products and services in several niche markets. DLJMB exited its position in the company subsequent to the Company’s initial public offering in June of 2000.
Headquarters: Wilmington, MA